We are live on ! Find out more
MEDP icon

Medpace

544 hedge funds and large institutions have $7.55B invested in Medpace in 2023 Q4 according to their latest regulatory filings, with 97 funds opening new positions, 201 increasing their positions, 181 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

185% more first-time investments, than exits

New positions opened: 97 | Existing positions closed: 34

63% more funds holding in top 10

Funds holding in top 10: 813 (+5)

35% more call options, than puts

Call options by funds: $40.5M | Put options by funds: $29.9M

30% more capital invested

Capital invested by funds: $5.81B → $7.55B (+$1.74B)

12% more funds holding

Funds holding: 487544 (+57)

11% more repeat investments, than reductions

Existing positions increased: 201 | Existing positions reduced: 181

2.19% more ownership

Funds ownership: 78.05%80.24% (+2.2%)

Holders
544
Holders Change
+57
Holders Change %
+11.7%
% of All Funds
7.92%
Holding in Top 10
13
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+62.5%
% of All Funds
0.19%
New
97
Increased
201
Reduced
181
Closed
34
Calls
$40.5M
Puts
$29.9M
Net Calls
+$10.6M
Net Calls Change
+$12.8M

MEDP Hedge Fund Activity: Q4 2023 in Review

544 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2023, worth a combined $7.55B — up 30% from $5.81B a quarter earlier.

Buyers outnumbered sellers: 97 funds opened new MEDP positions and 34 closed out — a net gain of 63 holders — while 201 added to existing stakes and 181 trimmed.

The largest buyer was TD Asset Management, adding an estimated $83.4M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $52.3M.

  • 544 institutional investors held Medpace (MEDP) as of Q4 2023, up from 487 in Q3 2023.
  • Funds reported $7.55B of Medpace stock for Q4 2023, up 30% quarter-over-quarter.
  • 97 funds opened new Medpace positions in Q4 2023 and 34 closed out, a net change of +63 holders.
  • The largest Medpace buyer in Q4 2023 was TD Asset Management, an estimated $83.4M added.
  • The largest Medpace seller in Q4 2023 was Fuller & Thaler Asset Management, an estimated $52.3M sold.

Based on aggregated 13F filings for Q4 2023.